Jane Street Group LLC Purchases 6,028,726 Shares of Senseonics Holdings, Inc. (NYSE:SENS)

Jane Street Group LLC increased its position in shares of Senseonics Holdings, Inc. (NYSE:SENS) by 6,694.1% during the fourth quarter, HoldingsChannel reports. The fund owned 6,118,786 shares of the company’s stock after buying an additional 6,028,726 shares during the quarter. Jane Street Group LLC’s holdings in Senseonics were worth $3,203,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of SENS. First Light Asset Management LLC bought a new position in Senseonics in the 4th quarter valued at approximately $3,366,000. Renaissance Technologies LLC bought a new position in shares of Senseonics during the fourth quarter valued at $720,000. Geode Capital Management LLC lifted its holdings in shares of Senseonics by 9.7% during the fourth quarter. Geode Capital Management LLC now owns 6,405,100 shares of the company’s stock worth $3,354,000 after purchasing an additional 566,704 shares during the period. XTX Topco Ltd bought a new stake in shares of Senseonics in the fourth quarter worth $179,000. Finally, Virtu Financial LLC acquired a new stake in Senseonics in the fourth quarter valued at $148,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

Senseonics Stock Performance

Shares of SENS stock opened at $0.60 on Wednesday. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The firm has a fifty day simple moving average of $0.65 and a two-hundred day simple moving average of $0.63. Senseonics Holdings, Inc. has a 12 month low of $0.25 and a 12 month high of $1.40. The firm has a market capitalization of $389.72 million, a PE ratio of -4.58 and a beta of 1.05.

Senseonics (NYSE:SENS) last announced its quarterly earnings results on Monday, March 3rd. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.09). Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. During the same quarter in the prior year, the firm posted ($0.07) earnings per share. Analysts forecast that Senseonics Holdings, Inc. will post -0.14 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on SENS. StockNews.com raised Senseonics to a “sell” rating in a research note on Monday. Mizuho initiated coverage on shares of Senseonics in a research report on Thursday, April 10th. They set an “outperform” rating and a $2.00 target price for the company. Finally, HC Wainwright restated a “buy” rating and issued a $2.00 price target on shares of Senseonics in a research report on Wednesday, March 5th.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.